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Abstract
 
We have analyzed a panel of T cell hybridomas specific for the chemically dominant epitope of
hen egg-white lysozyme 48–61 which has asparagine 59 as an important T cell receptor contact
residue. A number of T cells recognize 48–61 with asparagine at position 59, but not the aspar-
tic acid or isoaspartic acid derivatives. Conversely, we find T cells that specifically recognize
48–61 bearing an isoaspartic acid at residue 59, but not asparagine. For other T cells, aspar-
agine, aspartic acid, or isoaspartic acid at residue 59 is irrelevant. We present evidence that our
previous distinction between type A and type B T cells is not explained by asparagine deamida-
tion at residue 59.
Key words: class II major histocompatibility molecules • posttranslational modiﬁcation of 
peptides • lysozyme • antigen presentation • isoaspartate
 
Introduction
 
Some autoimmune diseases can be considered a result of
incomplete thymic negative selection or peripheral toler-
ance, resulting in the activation of T cells specific for autol-
ogous proteins. In evaluating these issues, we have been
examining the chemistry of peptides selected by class II
MHC molecules during antigen processing (summarized in
reference 1). We identified two sets of T cells that differed
in their recognition of the same peptide segment 48–61 of
hen-egg white lysozyme (HEL) (2–5). A “type A” T cell is
the conventional T cell that recognizes the MHC-bound
peptide resulting from the processing of the protein in the
processing vesicles. It also recognizes the peptide when of-
fered to APCs as an exogenous peptide, i.e., a form that
does not require intracellular processing. In contrast, a
“type B” T cell recognizes only the exogenous peptide but
not that derived from the processed protein. Using HEL as
a protein antigen, we have shown that type B T cells es-
caped thymic negative selection in HEL transgenic mice,
thus raising the issue that these T cells could be involved in
autoimmunity if an autologous protein is partially proteo-
lyzed in tissues (4).
One explanation for the features of type B T cells is that
they are recognizing changes in the exogenous peptide not
found in the naturally processed peptide. These changes
could occur during the handling of the peptide by the APC
or from its synthesis or postsynthetic modifications. Indeed,
peptide modifications are important in the context of T cell
recognition (for examples, see references 6 and 7), and one
such change involves the deamidation of asparagines in
proteins or peptides to yield aspartic acid and isoaspartic
acid. Mamula et al. reported the important finding that au-
tologous peptides containing an isoAsp modification were
immunogenic: immunization of mice with murine cyto-
chrome c peptide, residues 90–104, did not trigger T cell
proliferation, but immunization with the isoAsp containing
peptide was effective (8). Furthermore, immunization with
a peptide derived from a nuclear ribonucleoprotein having
the isoAsp also led to antibody production that cross-
reacted to the unmodified protein. These findings led Ma-
mula et al. to postulate the possible involvement of such
modifications in the autoimmunity of the lupus type.
A recent report claims that the type B T cells described
in our previous papers may react with a modification of
the exogenous peptide brought about by the spontaneous
conversion of Asn to Asp or isoAsp (9). Asn in the peptide
segment 52–60 of HEL is an important TCR contact
amino acid. Deamidation of Asn in proteins and peptides
yields isoAsp and Asp derivatives in the ratios of 
 
 
 
4:1 (10–
13). We demonstrate that an isoAsp residue can be specifi-
cally recognized by T cells, confirming the Mamula et al.
report at the clonal level. However, we refute the claim of
McAdam et al., as the evaluation of a number of T cell
clones indicates that the recognition of Asp or isoAsp is
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not the basis for the difference in the type A and type B
reactivity.
 
Materials and Methods
 
Antigen and Peptides.
 
HEL was purchased from Sigma-
Aldrich. HEL 48–61, (DGST
 
DYGILQINS
 
R), referred to as
48–61 N59, the segment in bold binds to I-A
 
k
 
 (14), was synthe-
sized using F-moc chemistry on a Synergy 430A peptide synthe-
sizer (Applied Biosystems). Peptide sequence and purity was con-
firmed by mass spectrometry. HEL 48–61 with isoAsp or Asp at
59 referred to as 48–61 
 
 
 
D59 and HEL 48–61 D59, respectively,
were provided by Dr. Garland Marshall (Washington University).
The binding of each peptide to purified I-A
 
k
 
 molecules was done
as reported (15) using baculovirus produced molecules in a com-
petitive binding assay.
 
Mice and Hybridomas.
 
The following hybridomas were gener-
ated as described previously: 3A9 (16), ALV 11, ALV48, and
DAV21 (3). The CP series of hybridomas was generated by im-
munization of B10.BR mice with 10 nmoles of HEL or 48–61 in
CFA. Hybridomas MLA11.2 and MLC10.22 were generated by
immunization of ML-5 transgenic mice (4, 5), expressing a se-
creted form of HEL with 10 nmoles of the tryptic fragment of
HEL, 46–61 in CFA. Hybridoma B10A6.5 was generated by im-
munization of B10.BR mice with 10 nmoles of the same tryptic
fragment. The Iso series of hybridomas were generated by immu-
nization of B10.BR mice with 10 nmoles of HEL48–61
 
 
 
D59.
We have used both male and female B10.BR mice which were
raised in the small animal facility of Washington University in St.
Louis, MO.
 
T Cell Assays.
 
T cell reactivity was determined by IL-2 se-
cretion. M12.C3.F6, a B lymphoma expressing I-A
 
k
 
 molecules
(5 
 
 
 
 10
 
4
 
) was incubated with decreasing doses of peptide in the
presence of T cell hybridomas (5 
 
 
 
 10
 
4
 
) in a total volume of 200
 
 
 
l in MEM with 10% fetal calf serum. Incubation was for 18 h,
followed by transfer of supernatants to wells containing CTLL-2,
an IL-2–dependent cell line. CTLL-2 were cultured for 40 h,
with [
 
3
 
H]thymidine added for the last 24 h. [
 
3
 
H]thymidine incor-
poration was determined using a Wallac 
 
 
 
 counter. Most of the
T cell hybridomas were tested against 48–61 peptide (batches
1255, 1387, or Abbt, with comparable results).
 
Quantitation of Isoaspartyl Content.
 
The isoaspartate content of
peptides was determined by a procedure based on the incorpora-
tion of radioactive methyl groups into isoaspartate residues, using
the enzyme protein isoaspartyl methyltransferase and S-adenosyl
L-(methyl)-
 
3
 
H methionine (obtained from Amersham Pharmacia
Biotech). We used and followed exactly the instructions in the
ISOQUANT kit from Promega (lot number 116482, catalog
number MA1010). We tested several batches of peptide that were
used for several years and kept stored in water at pH 3.
 
Results and Discussion
 
Previous structural and immunological studies indicated
that in the core segment of the 52–60 peptide of HEL, Asn
59 is a solvent exposed residue that contacts the TCR (14,
17, 18). Table I indicates that immunization with 48–61
 
 
 
D59 generated T cells specific for 48–61 
 
 
 
D59 peptide
that did not recognize the wild-type 48–61 N59 peptide.
These T cells reacted with as little as 0.1 to 0.3 
 
 
 
M of pep-
tide, and yet failed to be triggered by as much as 30 
 
 
 
M of
48–61 N59 (see iso.187 of Fig. 1). We also isolated T cells
that recognized specifically the 48–61 
 
 
 
D59 and the 48–61
D59 peptides (Table I).
A type A T cell is defined as reacting with both HEL as
well as to 48–61 (3, 4). A type B T cell will preferentially
recognize the peptide and will react poorly, if at all, to HEL.
A small response can be obtained at the high levels of HEL
in culture, of 30 to 100 
 
 
 
M. In Table I, all type A T cells
 
Table I.
 
Specificity of HEL48–61 Reactive T Cells
 
HEL48–61
N59 D59
 
 
 
D59
Type A CP4.1
 
        
 
CP4.22
 
     
 
/
 
    
 
3A9
 
       
 
ALV11
 
      
 
Type B ALV48
 
        
 
DAV21
 
        
 
/
 
 
 
CP3.43
 
          
 
CP3.42
 
          
 
CP3.12
 
       
 
B10A8.4
 
     
 
/
 
     
 
CP1.9
 
       
 
CP1.7
 
         
 
CP1.17
 
          
 
CP3.11
 
        
 
CP4.17
 
      
 
MLA11.2
 
       
 
/
 
 
 
B61.6
 
       
 
MLC10.22
 
      
 
CP2.11
 
      
 
B10A6.5
 
       
 
Isoaspartyl Iso.187
 
      
 
Iso.210
 
      
 
Iso.198
 
      
 
Iso.203
 
         
 
Iso.156
 
         
 
Patterns of reactivities to peptides among type A and B T cells. Type A
T cell hybridomas recognize native HEL and HEL48–61 N59 with
similar sensitivity, while type B hybridomas are at least 100-fold more
sensitive to peptide than to native HEL. Shown here is a list of T cell
hybridomas that follow the criteria for A and B T cells. References 3 and
4 have reported on the reactivity of many of these. The “Iso” series of
hybridomas were generated by immunization with HEL48–61
 
 
 
D59.
All hybridomas were tested against the following synthetic peptides:
HEL48–61 N59 (indicated as N59), HEL48–61D59 (D59), or
HEL48–61
 
 
 
D59 (
 
 
 
D59). For easier comparison, the sensitivity of the
hybridomas to the given peptides are represented as: 
 
   
 
 for 0.1 
 
 
 
M
or less, 
 
  
 
 for 1–10 
 
 
 
M, 
 
 
 
 for greater than 10 
 
 
 
M, 
 
 
 
/
 
 
 
 for trace
response, 
 
 
 
 for no response at the highest concentration tested. 
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were triggered by 
 
 
 
0.1 
 
 
 
M HEL, while none of the type B
were triggered up to 10 
 
 
 
M. When a number of type A and
type B T cells were examined for their response to the three
peptides, we found two patterns of reactivity: the first set re-
sponded to the three peptides with slight differences in the
sensitivities for each (CP4.1 and CP3.43; Fig. 1). The sec-
ond set only recognized the 48–61 N59 peptide, but not the
isoAsp or Asp derivatives (3A9, B61.6, and B10.A6.5; Fig.
1). These two sets were found in both type A and B subsets.
Two of four type A T cells only recognized the 48–61 N59,
while the other two did not discriminate among the Asn,
Asp, and isoAsp 59 residues. Likewise, 5 of 16 type B T cells
were completely specific for the N59 TCR contact residue,
while the remaining 11 had variable degrees of responses
among the three peptides. Studies are now being done to
examine the use of the various TCR contact residues among
these different T cells.
The finding that the wild-type peptide, 48–61 N59, was
recognized uniquely by either A and B types while, con-
versely, the 48–61 
 
 
 
D59 specific T cells failed to recognize
it, argues strongly that spontaneous conversion of the Asn
59 TCR contact residue in the 48–61 N59 peptide is not
the explanation for the type B specificity. We also tested
for the degree of isoAsp conversion in each of the peptides
used in the past 6 yr. These peptides were repeatedly used
and kept in the laboratory under various temperature con-
ditions. Using the incorporation of radioactive methyl
groups, we failed to find significant levels of isoaspartyl
Figure 1. Type A and type B hybridomas were tested for responses to HEL48–61 N59 ( ), HEL48–61D59 ( ), and HEL48–61 D59 ( ). T cell hy-
bridomas were incubated with M12.C3.F6, a B lymphoma expressing I-Ak, and the designated amount of peptide overnight. T cell recognition was mea-
sured by IL-2 secretion, as determined by incubation of assay supernatant with the IL-2–dependent cell line, CTLL-2, and incorporation of [3H]thymi-
dine. Iso.187, and Iso.210 (in Table I) did not respond to native HEL, denatured HEL, and 48–61N59 at concentrations up to 30  M.
 
Table II.
 
Isoaspartyl Content of Peptides
 
Peptide Batch (date) cpm/pmol
pmol
(percentage
of isoaspartyl)
48–61 388 (1/96) 0 0 (0%)
48–61 924 (11/97) 971 0.6 (0.2%)
48–61 1255 (4/99) 75 0.4 (0.2%)
48–61 1317 (7/99) 31,083 17.7 (7.1%)
48–63 1387 (8/99) 508 0.3 (0.1%)
48–63 Abbt (6/98) 0 0 (0%)
46–61 RD (7/00) 3,716 2.1 (0.9%)
 
Isoaspartyl content of peptides. Each preparation was tested at 250 pmol.
With the standard provided by the manufacturer, the cpm per pmol was
estimated at 1,754. Peptides had been made at the indicated dates and
stored frozen or at 4
 
 
 
C
 
. The various peptides had been used to generate
and evaluate the cells shown in Table I. The above data has been selected
from a series of experiments performed during April and May, 2000.
Peptide 1317 was made in another laboratory and never used in these
experiments. 46–61 refers to a tryptic peptide from HEL. The peptide
labeled “Abbt” was produced by a commercial source. The preparation of
48–61 
 
 
 
D59 was tested at 125 pmol and found to bind 98% of the
radioactive material. 
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conversion in 6/7 preparations that were tested (Table II).
Whether the Asn in these peptides is converted during the
assay becomes irrelevant in light of the results with T cells.
Indeed, based on the sensitivities of the T cells indicated
above, the amount of spontaneous isoAsp conversion of the
48–61 N59 peptide must be limited to 
 
 
 
1% in the 18 h of
the assay. Finally, we found only slight differences in bind-
ing of the three peptides to purified I-A
 
k
 
 molecules, with
IC 50% of 0.12, 0.24, and 0.82 
 
 
 
M for 48–61 N59,48–61
D59, and 48–61 
 
 
 
D59, respectively.
In summary, our results extend the report by Mamula et
al., calling attention to the fact, using cloned cells, that T
cells can make an important discrimination between Asn,
Asp, and isoAsp residues in a peptide. This discrimination is
important in the context of changes that may take place in
autologous proteins in tissues, as they correctly speculated.
It is also important in the context of peptides made in the
laboratory (8): as noted, one of our peptides (1317 in Table
II) had 17% of conversion and could have induced specific
T cells. In our case, the importance of this issue is high-
lighted because Asn 59 has been documented as a solvent
exposed residue available for T cell recognition of the 52–
60 core segment of the HEL peptide.
From a thorough analysis of a large panel of T cell hy-
bridomas, it is obvious that the recognition of Asp or
isoAsp at the TCR contact residue 59, which is P8 in the
peptide, is independent of the type A and type B states and
is not the feature that distinguishes them. Concerning the
claim made in the McAdam et al. paper we contend that
conclusions are difficult to make on one or two T cells,
particularly when the issue of sensitivity in the various ma-
nipulations of the assays are not taken into consideration.
Also, to note that other HEL peptides in which we found
the type A and type B T cells did not have the sequence of
Asn followed by the Ser or Gly, the destabilizing residues
that favor the deamidation. These include the 84–96 pep-
tide (2).
We made the distinction between type A and B T cells
based on our identification of the natural processed pep-
tides of HEL, from which we identified and quantitated
their amounts displayed after processing. The surprise was
that offering the identical peptide to APCs induced a novel
reactivity—type B—which was not displayed by the en-
dogenous processing of HEL. As the linear sequence was
identical (and not explained by postsynthetic modifica-
tions), we have sought alternative explanations. The best
explanation for the type B state of a peptide-MHC com-
plex is that it results from a unique conformation (3, 4)
formed when exogenous peptides bind to class II molecules
in early endosomal compartments or on plasma membrane,
as described in reference 19. This conformation is distinct
from the type A that results when peptides bind from a
processed protein to a nascent class II molecule in the pro-
cessing compartments. As mentioned, the importance of
type B T cells is that many escape thymic negative selection
and peripheralize, representing a set of T cells that can po-
tentially react with peptides formed at sites of inflammation
(4, 5).
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